NFG
ELOS

Next Financial Group’s Syneron Medical Ltd ELOS Stock Holding History

Next Financial Group’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-300
Closed -$3K – 2046
2017
Q2 		$3K Hold
300
– – ﹤0.01% 1703
2017
Q1 		$3K Sell
300
-300
-50% -$2.9K ﹤0.01% 1660
2016
Q4 		$5K Hold
600
– – ﹤0.01% 1960
2016
Q3 		$4K Hold
600
– – ﹤0.01% 2034
2016
Q2 		$4K Hold
600
– – ﹤0.01% 1490
2016
Q1 		$4K Hold
600
– – ﹤0.01% 1452
2015
Q4 		$4K Hold
600
– – ﹤0.01% 1486
2015
Q3 		$4K Hold
600
– – ﹤0.01% 1519
2015
Q2 		$6K Hold
600
– – ﹤0.01% 1453
2015
Q1 		$7K Hold
600
– – ﹤0.01% 1405
2014
Q4 		$6K Hold
600
– – ﹤0.01% 1462
2014
Q3 		$6K Hold
600
– – ﹤0.01% 2014
2014
Q2 		$6K Buy
+600
New +$6.49K ﹤0.01% 897

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Next Financial Group's ELOS Position: Q3 2017 in Review

Next Financial Group sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 300 shares — an estimated $3K sold.

Next Financial Group first reported a position in ELOS in Q2 2014 and held it in 13 quarters. The position peaked at $7K in Q1 2015. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Next Financial Group reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Next Financial Group sold 300 Syneron Medical Ltd shares in Q3 2017, an estimated $3K.
  • Next Financial Group first reported a position in Syneron Medical Ltd in Q2 2014 and held it in 13 quarters.
  • Next Financial Group's Syneron Medical Ltd position peaked at $7K in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Next Financial Group's 13F filing for Q3 2017, filed 8 Nov 2017.